Reference
Svensson M, et al. Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. PharmacoEconomics : 12 Jun 2015. Available from: URL: http://dx.doi.org/10.1007/s40273-015-0307-6
Rights and permissions
About this article
Cite this article
Decision makers use higher WTP threshold than expected. PharmacoEcon Outcomes News 731, 13 (2015). https://doi.org/10.1007/s40274-015-2242-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2242-3